Novel therapy for neurological disorders and cardiac arrhythmias
based on Cell Therapy.
Employees: 7
Overview
GeneGrafts LTD is a biotechnology company developing proprietary
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
technology for modulating excitable tissues (e.g. Brain, Heart).
This new paradigm can be used for the treatment of various
diseases including Parkinson's disease and other neurological
disorders, and cardiac arrhythmias.
GeneGrafts is based in the Technological Incubator founded by the
Technion R&D Foundation Ltd. The company has raised seed funding
from the Office of the Chief Scientist of the Israeli Ministry of
Industry and Trade, 4 major Venture Capital funds and a large
international strategic partner, and began operations in November
2003.
